Ewelina has over 15 years of hands-on bioscience research experience, specialising in cell biology, drug discovery and regenerative medicine. She has worked with both academia and industry on pre-clinical projects ranging from early proof of concept to final drug candidate nomination, focusing on cancer research and neurodegenerative disorders.

Most recently she was responsible for development and translation of pre-clinical research protocols to clinical and regulatory ready manufacturing processes for personalised tissue engineered products targeting respiratory and immunological disorders at a SME in Leeds.

Ewelina has worked on multiple interdisciplinary programs, supporting pre-clinical hit to lead optimisation, assay and drug development, and clinical translation of advanced therapies; collaborating with big pharma companies and academia.